Offerings // BioXcel Therapeutics, Inc.

BTAI offering history

Every offering-related filing in BioXcel Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 667 filings back to Nov 13, 2017.

Last executed offering
Apr 17, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Jan 10, 2025
S-3 — capacity, not a sale
Executed, last 12 months
3
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Apr 17, 20268-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 11, 2026424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 18, 2025424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 6, 2025424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 3, 2025424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 4, 2025424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 17, 2025EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jan 10, 2025S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Nov 25, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 21, 20248-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Nov 21, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 4, 2024424B7UPDATEResale prospectus — existing holders registering to sell
Mar 25, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 8, 2024424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 22, 2024EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jan 12, 2024S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 6, 20238-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Nov 14, 2023424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 13, 2023RWWITHDRAWNRegistration withdrawn
Nov 13, 2023EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Nov 2, 2023S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 16, 2022EFFECTEFFECTIVESEC declared a registration effective — selling can begin
May 27, 2022S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Apr 19, 20228-KEXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 7, 2022EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Jun 24, 2021424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 22, 2021424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 10, 2021424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 30, 2020424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 27, 2020S-3ASRREGISTEREDAutomatic shelf registration — effective immediately (large filers)
Jul 27, 2020424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 21, 2020424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 19, 2020424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 27, 2019424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 25, 2019424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 20, 2019424B5EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 4, 2019EFFECTEFFECTIVESEC declared a registration effective — selling can begin
Apr 1, 2019RWWITHDRAWNRegistration withdrawn
Apr 1, 2019S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 14, 2019S-3REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
BTAI offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full BTAI workspace →
BTAI offering FAQ

When did BTAI last execute an offering?

Per SEC filings, BioXcel Therapeutics, Inc.'s most recent priced offering document is a 8-K filed 2026-04-17. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did BTAI last announce or register an offering?

The most recent registration is a S-3 filed 2025-01-10. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.